Merck, Pfizer COVID-19 Antivirals Different From Ivermectin

Posted on AllSides October 17th, 2021
From The Center
Merck Sharp

Merck and Pfizer are each developing a new oral antiviral drug that might prevent or treat COVID-19. The pills are very different from the antiparasitic medication ivermectin, contrary to claims online that they are “suspiciously similar” or that the companies are “repackaging” ivermectin in a ploy to increase profits.

Throughout the COVID-19 pandemic, there has not been an easy-to-take oral pill that can prevent or treat infection with SARS-CoV-2, the coronavirus that causes COVID-19. Pharmaceutical companies, however, have been working on testing novel drug candidates, and in the last few weeks...

Read full story

AllSides Media Bias Rating: Center
AllSides Media Bias Rating: Center
See full bias rating for
Learn about media bias

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right